Skip to content

Repeated infusions of ketamine show cumulative benefits for depression

The Brown University Psychopharmacology Update July 1, 2019 DOI: 10.1002/pu.30446 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Population Patients with treatment-resistant depression
Intervention Ketamine
Duration Six infusions over 2 weeks (three times a week), followed by a final phase of weekly infusions
Topics Depression Esketamine Ketamine
Key points Six ketamine infusions administered three times a week over two weeks produced cumulative and sustained antidepressant effects in patients with treatment-resistant depression, and among responders, antidepressant response was generally maintained with weekly infusions during the study's final phase.

Abstract

A study examining the effects of single, repeated, and maintenance doses of ketamine on patients with treatment‐resistant depression has found cumulative and sustained antidepressant effects from six infusions administered three times a week over 2 weeks. The study also found that among responders to the repeated infusions, antidepressant response was generally maintained with weekly infusions in the study's final phase.

Explore topics

By condition and practice